First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Trading Down 1.7% – Here’s Why

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) shares fell 1.7% during mid-day trading on Thursday . The company traded as low as $33.95 and last traded at $34.00. 1,467 shares were traded during mid-day trading, a decline of 81% from the average session volume of 7,671 shares. The stock had previously closed at $34.59.

First Trust Nasdaq Pharmaceuticals ETF Stock Performance

The stock has a market capitalization of $30.52 million, a P/E ratio of 14.51 and a beta of 0.47. The firm has a 50-day moving average price of $34.14 and a 200 day moving average price of $33.25.

First Trust Nasdaq Pharmaceuticals ETF Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 31st. Shareholders of record on Thursday, March 26th were given a dividend of $0.0573 per share. This represents a $0.23 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date was Thursday, March 26th.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. NBC Securities Inc. boosted its stake in shares of First Trust Nasdaq Pharmaceuticals ETF by 33.0% in the 4th quarter. NBC Securities Inc. now owns 1,325 shares of the company’s stock valued at $44,000 after purchasing an additional 329 shares in the last quarter. Raymond James Financial Inc. bought a new stake in First Trust Nasdaq Pharmaceuticals ETF in the second quarter worth $57,000. Kestra Advisory Services LLC bought a new stake in First Trust Nasdaq Pharmaceuticals ETF in the fourth quarter worth $59,000. Flagship Harbor Advisors LLC purchased a new stake in First Trust Nasdaq Pharmaceuticals ETF during the fourth quarter valued at about $205,000. Finally, Stratos Wealth Partners LTD. purchased a new stake in First Trust Nasdaq Pharmaceuticals ETF during the third quarter valued at about $230,000.

About First Trust Nasdaq Pharmaceuticals ETF

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.